ArticleKidney international reports2020

Early Use of Rituximab in Calcineurin Inhibitor-Refractory and Steroid-Resistant Nephrotic Syndrome.

Rajiv Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.